A membrane protein encoded by Epstein-Barr virus in latent growth-transforming infection
- PMID: 6095274
- PMCID: PMC392107
- DOI: 10.1073/pnas.81.22.7207
A membrane protein encoded by Epstein-Barr virus in latent growth-transforming infection
Abstract
The nucleotide sequence of an Epstein-Barr virus gene expressed in latently infected growth-transformed cells is known to include a long open reading frame containing a 33-base-pair repeat element. A bacterial fusion protein constructed from a portion of the reading frame and Escherichia coli beta-galactosidase was used to produce sera in rabbits against the previously unidentified gene product. The viral protein detected with these sera in latently infected cells varies in size with the number of copies of the DNA repeat element. Translation of the RNA in vitro yields a protein of similar size. As expected from its primary sequence, the protein is a membrane protein. Immunofluorescence studies with the rabbit antisera suggest that the protein is in the plasma membrane. Thus, this protein could be the lymphocyte-determined membrane antigen (LYDMA) responsible for the generation of T-cell immunity to latently infected cells.
Similar articles
-
A second nuclear protein is encoded by Epstein-Barr virus in latent infection.Science. 1985 Mar 8;227(4691):1238-40. doi: 10.1126/science.2983420. Science. 1985. PMID: 2983420
-
Biochemistry of latent Epstein-Barr virus infection and associated cell growth transformation.IARC Sci Publ. 1985;(60):323-39. IARC Sci Publ. 1985. PMID: 2998995
-
Orientation and patching of the latent infection membrane protein encoded by Epstein-Barr virus.J Virol. 1986 Apr;58(1):233-7. doi: 10.1128/JVI.58.1.233-237.1986. J Virol. 1986. PMID: 3005654 Free PMC article.
-
LYDMA-antigens and immunity against EBV-infected cells Epstein-Barr virus as a model for the study of host-infection interaction.Int J Biol Markers. 1987 May-Aug;2(2):125-32. doi: 10.1177/172460088700200212. Int J Biol Markers. 1987. PMID: 2837523 Review.
-
Evolving principles in immunopathology: interleukin 10 and its relationship to Epstein-Barr virus protein BCRF1.Springer Semin Immunopathol. 1991;13(2):157-66. doi: 10.1007/BF00201466. Springer Semin Immunopathol. 1991. PMID: 1664983 Review. No abstract available.
Cited by
-
A bicistronic Epstein-Barr virus mRNA encodes two nuclear proteins in latently infected, growth-transformed lymphocytes.J Virol. 1987 Apr;61(4):945-54. doi: 10.1128/JVI.61.4.945-954.1987. J Virol. 1987. PMID: 3029429 Free PMC article.
-
Epstein-Barr virus gene expression in malignant lymphomas induced by experimental virus infection of cottontop tamarins.J Virol. 1989 May;63(5):1967-74. doi: 10.1128/JVI.63.5.1967-1974.1989. J Virol. 1989. PMID: 2539497 Free PMC article.
-
Epstein-Barr virus nuclear antigen 2 induces expression of the virus-encoded latent membrane protein.J Virol. 1990 May;64(5):2126-34. doi: 10.1128/JVI.64.5.2126-2134.1990. J Virol. 1990. PMID: 2157875 Free PMC article.
-
Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23.J Virol. 1990 May;64(5):2309-18. doi: 10.1128/JVI.64.5.2309-2318.1990. J Virol. 1990. PMID: 2157887 Free PMC article.
-
Identification of Epstein-Barr virus terminal protein 1 (TP1) in extracts of four lymphoid cell lines, expression in insect cells, and detection of antibodies in human sera.J Virol. 1990 Jun;64(6):2759-67. doi: 10.1128/JVI.64.6.2759-2767.1990. J Virol. 1990. PMID: 2159542 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials